Vicarious Surgical to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

Rhea-AI Summary

Vicarious Surgical Inc. (NYSE: RBOT, RBOT WS) will present at the Canaccord Genuity MedTech, Diagnostics, and Digital Health & Services Forum on November 18 at 4:00 p.m. Eastern Time. The management will also engage in virtual investor meetings throughout the day. The presentation will be live-streamed on the Company’s website, with an archive available afterward. Vicarious Surgical specializes in innovative robotics technology aimed at enhancing surgical efficiency and patient outcomes.

WALTHAM, Mass.--(BUSINESS WIRE)-- Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both cost and efficiency of surgical procedures, today announced that management will participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum. Management is scheduled to present on Thursday, November 18^th at 4:00 p.m. Eastern Time and will participate in virtual investor meetings throughout the day.

A live webcast of the presentation will be accessible to the public on the Company's website at https://investor.vicarioussurgical.com/. An archive of the webcast will be available for replay following the conference.

About Vicarious Surgical

Founded in 2014, Vicarious Surgical is a next-generation robotics company developing a disruptive technology with the goals of increasing the efficiency of surgical procedures, improving patient outcomes and reducing healthcare costs. The Company’s novel surgical approach uses a combination of proprietary human-like surgical robots and virtual reality to transport surgeons inside the patient to perform minimally invasive surgery. The Company’s technology was granted Breakthrough Device Designation by the FDA, and Vicarious Surgical believes the Vicarious System is the first surgical robot to receive this designation from the FDA. The Company is led by an experienced team of technologists, medical device professionals and physicians, and is backed by technology luminaries including Bill Gates, Vinod Khosla’s Khosla Ventures, Innovation Endeavors, Jerry Yang’s AME Cloud Ventures, Sun Hung Kai & Co. Ltd and Philip Liang’s E15 VC. The Company is headquartered in Waltham, Mass. Learn more at www.vicarioussurgical.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211104005816/en/

Investor Contact

Lynn Lewis or Marissa Bych

Gilmartin Group

ir@vicarioussurgical.com

Press and Media Inquiries:

Jill Gross

Matter Communications

media@vicarioussurgical.com

Source: Vicarious Surgical Inc.

FAQ

When is Vicarious Surgical presenting at the Canaccord Genuity Forum?

Vicarious Surgical will present on November 18 at 4:00 p.m. Eastern Time.

Where can I watch the Vicarious Surgical presentation?

The presentation will be live-streamed on Vicarious Surgical's website.

What is the stock symbol for Vicarious Surgical?

The stock symbol for Vicarious Surgical is RBOT, WS.

What technology does Vicarious Surgical develop?

Vicarious Surgical develops next-generation robotics technology for minimally invasive surgery.

What recognition has Vicarious Surgical's technology received?

Vicarious Surgical's technology was granted Breakthrough Device Designation by the FDA.